Improving long-term renal allograft survival via a road less traveled by

Mark D Stegall, W. D. Park, P. G. Dean, Fernando G Cosio

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

It has become cliché to state that improvements in early renal allograft survival over the past two decades have not led to increased long-term renal allograft survival. However, it is not clear how long-term graft survival can be improved. Here, we present the viewpoint that the road forward does not involve searching for new and more ideal immunosuppressive regimens, but rather detailed patient follow-up to identify specific causes of late renal allograft loss and the development of new therapy designed to address these problems before allograft damage becomes irreversible.

Original languageEnglish (US)
Pages (from-to)1382-1387
Number of pages6
JournalAmerican Journal of Transplantation
Volume11
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Allografts
Kidney
Graft Survival
Immunosuppressive Agents
Therapeutics

Keywords

  • Allograft nephropathy
  • chronic rejection
  • immunosuppressive therapy
  • kidney transplantation
  • long-term graft survival

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Improving long-term renal allograft survival via a road less traveled by. / Stegall, Mark D; Park, W. D.; Dean, P. G.; Cosio, Fernando G.

In: American Journal of Transplantation, Vol. 11, No. 7, 07.2011, p. 1382-1387.

Research output: Contribution to journalArticle

Stegall, Mark D ; Park, W. D. ; Dean, P. G. ; Cosio, Fernando G. / Improving long-term renal allograft survival via a road less traveled by. In: American Journal of Transplantation. 2011 ; Vol. 11, No. 7. pp. 1382-1387.
@article{99aadc533ad34df7a72ca77a6c2ac087,
title = "Improving long-term renal allograft survival via a road less traveled by",
abstract = "It has become clich{\'e} to state that improvements in early renal allograft survival over the past two decades have not led to increased long-term renal allograft survival. However, it is not clear how long-term graft survival can be improved. Here, we present the viewpoint that the road forward does not involve searching for new and more ideal immunosuppressive regimens, but rather detailed patient follow-up to identify specific causes of late renal allograft loss and the development of new therapy designed to address these problems before allograft damage becomes irreversible.",
keywords = "Allograft nephropathy, chronic rejection, immunosuppressive therapy, kidney transplantation, long-term graft survival",
author = "Stegall, {Mark D} and Park, {W. D.} and Dean, {P. G.} and Cosio, {Fernando G}",
year = "2011",
month = "7",
doi = "10.1111/j.1600-6143.2011.03557.x",
language = "English (US)",
volume = "11",
pages = "1382--1387",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Improving long-term renal allograft survival via a road less traveled by

AU - Stegall, Mark D

AU - Park, W. D.

AU - Dean, P. G.

AU - Cosio, Fernando G

PY - 2011/7

Y1 - 2011/7

N2 - It has become cliché to state that improvements in early renal allograft survival over the past two decades have not led to increased long-term renal allograft survival. However, it is not clear how long-term graft survival can be improved. Here, we present the viewpoint that the road forward does not involve searching for new and more ideal immunosuppressive regimens, but rather detailed patient follow-up to identify specific causes of late renal allograft loss and the development of new therapy designed to address these problems before allograft damage becomes irreversible.

AB - It has become cliché to state that improvements in early renal allograft survival over the past two decades have not led to increased long-term renal allograft survival. However, it is not clear how long-term graft survival can be improved. Here, we present the viewpoint that the road forward does not involve searching for new and more ideal immunosuppressive regimens, but rather detailed patient follow-up to identify specific causes of late renal allograft loss and the development of new therapy designed to address these problems before allograft damage becomes irreversible.

KW - Allograft nephropathy

KW - chronic rejection

KW - immunosuppressive therapy

KW - kidney transplantation

KW - long-term graft survival

UR - http://www.scopus.com/inward/record.url?scp=79959852367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959852367&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2011.03557.x

DO - 10.1111/j.1600-6143.2011.03557.x

M3 - Article

C2 - 21564533

AN - SCOPUS:79959852367

VL - 11

SP - 1382

EP - 1387

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 7

ER -